POORLY DIFFERENTIATED THYROID CARCINOMA
Clinical trials for POORLY DIFFERENTIATED THYROID CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new POORLY DIFFERENTIATED THYROID CARCINOMA trials appear
Sign up with your email to follow new studies for POORLY DIFFERENTIATED THYROID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug duo targets tough thyroid cancers
Disease control Recruiting nowThis study is testing whether a new two-drug combination can help people with advanced thyroid cancer that has stopped responding to standard treatments. The trial will enroll 94 adults with specific types of aggressive thyroid cancer. Researchers will give different drug combina…
Matched conditions: POORLY DIFFERENTIATED THYROID CARCINOMA
Phase: NA • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Radioactive 'Tumor Seeker' drug tested in patients with advanced cancers
Disease control Recruiting nowThis is a very early study to test the safety of a new radioactive drug called [177Lu]Lu-AKIR001 in adults with advanced solid tumors that have a specific marker called CD44v6. The main goal is to find out what side effects occur and how much of the drug the body can handle. Rese…
Matched conditions: POORLY DIFFERENTIATED THYROID CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC